Scinovex
article Open Access

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Genes & Development · 1998 · Vol. 12(9) · pp. 1260–1268
Nathan BucayIldiko SarosiColin R. DunstanSean MoronyJ E TarpleyC. CapparelliSheila ScullyHong‐Lin TanWeili XuDavid L. LaceyW. J. BoyleW. Scott Simonet

Abstract

Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG-/- mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly, OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.

Bone Metabolism and DiseasesBone health and treatmentsBone health and osteoporosis researchOsteoprotegerinCalcificationInternal medicineOsteoporosisEndocrinologyRANKLBiologyOsteoclastBone remodelingRegulator

MeSH terms

AnimalsArteriesCalcinosisDisease Models, AnimalFemaleGlycoproteinsMaleOsteoporosisVascular DiseasesBone DensityIn Situ HybridizationReceptors, Tumor Necrosis FactorReceptors, Cytoplasmic and NuclearMice, KnockoutGene Targeting
Citations
2,471
FWCI
field-weighted impact
References
44
Percentile
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.